Veterinary
APIs
Pioneering veterinary ingredient innovation and manufacturing with added expertise
At Suanfarma, we are committed to preserving the health and well-being of animals. That is why, in our Veterinary API division, we offer an extensive portfolio of products to meet the needs of all our customers.
We have over 250 active molecules covering all therapeutic areas of veterinary medicine, including antibiotics, antiparasitics, anti-inflammatories, and products for the treatment of metabolic, endocrine and cardiovascular diseases, among others. We are committed to supporting our customers in their new developments, whether they involve current market alternatives or future projects, providing assistance through global market analysis and expertise.
We ensure compliance with the strictest Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and quality standards, thereby guaranteeing the highest quality of products for our clients. Additionally, we offer comprehensive Regulatory and Quality support to our customers to ease the development of their products.
Proprietary APIs
Proprietary APIs
THERAPEUTIC INDICATION | API | CEP/DMF | STATUS |
|---|---|---|---|
| ANTIBIOTIC | OXYTETRACYCLINE DIHYDRATE | COMMERCIAL | |
| TIAMULIN FUMARATE | CEP, VFM | COMMERCIAL | |
| ANTIPARASITIC | FLURALANER | COMMERCIAL | |
| DERMATITIS CONTROL AGENT | OCLACITINIB | UNDER DEVELOPMENT | |
| OVULATION STIMULANT | CLOMIFENE CITRATE | CEP | COMMERCIAL |
Under development APIs
AFOXOLANER
CEFOVECIN SODIUM
FLURALANER
IMEPITOIN
KETAMINE HCL – CEP
OCLACITINIB MALEATE
PENTOBARBITAL SODIUM – DMF/CEP
PYRANTEL PAMOATE – CEP
TILDIPIROSIN
TRILOSTANE
*Products under valid patents are not offered or supplied for commercial use and are only available for R&D in accordance with applicable legislation.
Strategic APIs
THERAPEUTIC INDICATION | API | CEP/DMF | STATUS |
|---|---|---|---|
| ANTIBIOTIC | AZITHROMYCIN | CEP, DMF | COMMERCIAL |
| CIPROFLOXACIN | CEP, DMF | COMMERCIAL | |
| ENROFLOXACIN | CEP, DMF | COMMERCIAL | |
| FLORFENICOL | COMMERCIAL | ||
| MARBOFLOXACIN | CEP, DMF | COMMERCIAL | |
| TILDIPIROSIN | CEP | COMMERCIAL | |
| ANTIEPILEPTIC | IMEPITOIN | COMMERCIAL | |
| ANTIPROTOZOAL | DICLAZURIL | CEP, DMF | COMMERCIAL |
| OPIOID | TRAMADOL HYDROCHLORIDE | CEP, DMF | COMMERCIAL |
| PERIPHERAL VASODILATOR | PROPENTOFYLLINE | COMMERCIAL | |
| PROTON PUMP INHIBITOR | OMEPRAZOL FORM B | CEP | COMMERCIAL |
| SECRETOLYTIC | DEMBREXINE | COMMERCIAL |
API+
This model consists in manufacturing APIs in combination with development of the FDF technology.
We provide a stable FDF manufacturing technology fully compatible with the active ingredient.
- FDF dossier at lab scale: formulation, validation, stability report, including API.
- API: DMF in CTD format, EU GMP facilities, technical support.
APIs
Specialized
products with
studies and
available clinical
data
Other products developed & manufactured under exclusive basis
Our wide experience backs us up
Contact us and we will provide you with details of our extensive product portfolio.
If you can´t find the product you are looking for, or you are interested in developing a new product, please contact us.
Other products developed & manufactured under exclusivity
Our broad experience backs us up
If you cannot find the product you are looking for, or you are interested in developing a new product, please contact us.
